Institute for Quality and Efficiency in Health Care

The Institute for Quality and Efficiency in Healthcare (IQWiG) (German: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions (e.g. surgical procedures), diagnostic and screening methods, and treatment and disease management. IQWiG also supplies health information to patients and the general community. The organization is independent of the pharmaceuticals industry, contracted solely by the Federal Ministry of Health and the Joint Federal Committee. IQWiG was founded in 2004 under the directorship of Dr Peter Sawicki, who was in September 2010 replaced by Dr Jürgen Windeler. Its deputy director is Dr Stefan Lange. IQWiG is divided into the following departments, which publish reports: General health information, written in plain language, is additionally produced by a Health Information department. These departments are also supported by Administration and Communication departments.

Website
http://www.iqwig.de/
Wikipedia
http://en.wikipedia.org/wiki/Institute_for_Quality_and_Efficiency_in_Health_Care

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Plants & Animals

First rebbachisaurid dinosaur remains found in Asia

A pair of researchers with the Russian Academy of Sciences and the National Museum of Natural History in the U.S., respectively, has respectively, uncovered the first known example of a rebbachisaurid dinosaur to be found ...

Bio & Medicine

Tiny bubble study could improve dentists' tools

People's teeth-chattering experiences in the dentist's chair could be improved by fresh insights into how tiny, powerful bubbles are formed by ultra-fast vibrations, a study suggests.

Psychology & Psychiatry

Gut health and mood genetically entwined

University of Queensland researchers have confirmed a link between depression and stomach ulcers, in the world's largest study of genetic factors in peptic ulcer disease.

Biotechnology

Targeting COVID-19 with innovative computational design methods

Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics—exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication ...

page 1 from 27